Pharmaceutical sustainability

ESG HUB > News >
16 Dec
What are the ESG materiality issues in the pharmaceutical sector in Switzerland?
Category: Blog
“The pharmaceutical sector in Switzerland is a major industry, accounting for approximately 7% of GDP, and 35% of manufacturing.” The Swiss pharma business is the largest pharma bu...
16 Jul
Novartis packaging 2
Novartis is committed to become plastic neutral by 2030
Category: ESG News
By the end of World War I, Emerson’s annual sales approach $3 million dollars. Under the leadership, the company expands into a new.